SynthesisEndocrinology, diabetes & metabolism2026
Glycaemic and Cardiometabolic Outcomes of Empagliflozin Versus Sitagliptin Added to Metformin in T2DM: Insights From a Systematic Review and Meta-Analysis.
Saad Ashraf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.